Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Zai Lab Ltd (ZLAB)
|
Add to portfolio |
|
|
|
| Price: |
$59.60
| | Metrics |
| OS: |
1.73
|
B
| |
-42
|
% ROE
|
| Market cap: |
$103
|
B
| |
-255
|
% ROIC
|
|
Net cash:
|
$880
|
M
| |
$0.51
|
per share
|
|
EV:
|
$102
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($386)
|
M
| |
|
|
|
EBIT
|
($395)
|
M
| |
|
|
| EPS |
($0.41)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 215.0 | 144.3 | 49.0 | 13.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Revenue growth | 49.0% | 194.8% | 277.0% | 9965.9% | | | | |
| Cost of goods sold | 74.0 | 52.2 | 16.7 | 3.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 141.0 | 92.1 | 32.2 | 9.2 | 0.1 | 0.0 | 0.0 | 0.0 |
| Gross margin | 65.6% | 63.8% | 65.8% | 71.1% | 66.7% | | | |
| Selling, general and administrative | 259.0 | 218.8 | 111.3 | 70.2 | 21.6 | 12.0 | 6.4 | |
| Research and development | 286.4 | 573.3 | 222.7 | 142.2 | 120.3 | 39.3 | 32.1 | 13.6 |
| General and administrative | | | | | | | | 2.8 |
| EBITA | -404.1 | -700.6 | -302.6 | -203.6 | -142.3 | -51.4 | -38.5 | -16.3 |
| EBITA margin | -187.9% | -485.5% | -618.1% | -1568.3% | -110341.1% | | | |
| Amortization of intangibles | 0.5 | 0.5 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT | -404.6 | -701.1 | -302.9 | -203.9 | -142.4 | -51.4 | -38.5 | -16.3 |
| EBIT margin | -188.1% | -485.8% | -618.7% | -1570.6% | -110352.7% | | | |
| Pre-tax income | -443.3 | -704.5 | -268.9 | -194.3 | -139.1 | -50.4 | -37.5 | -18.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -443.3 | -704.5 | -268.9 | -195.1 | -139.1 | -50.4 | -37.5 | -18.0 |
| Net margin | -206.1% | -488.2% | -549.3% | -1502.3% | -107810.1% | | | |
| |
| Diluted EPS | ($0.46) | ($0.76) | ($0.35) | ($3.03) | ($2.64) | ($2.32) | ($3.97) | ($2.07) |
| Shares outstanding (diluted) | 958.1 | 929.9 | 776.7 | 64.4 | 52.6 | 21.8 | 9.4 | 8.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|